Best practices for cryopreserving, thawing, recovering, and assessing cells
Baust, Campbell, Harbell. Best practices for cryopreserving, thawing, recovering, and assessing cells. In Vitro Cell.Dev.Biol.—Animal. DOI 10.1007/s11626-017-0201-y
Tag: CS
Cell therapy post-production technologies: a select review of key innovations in the field
Thompson, Schryver, Ehrhardt. Cell therapy post-production technologies: a select review of key innovations in the field. Cell Gene Therapy Insights 2017; 433-441.DOI: 10.18609/cgti.2017.049
Applications and optimization of cryopreservation technologies to cellular therapeutics
Fuller, Gonzalez-Molina, Erro, Mendonca, Chalmers, Awan, Poirier, Selden. Applications and optimization of cryopreservation technologies to cellular therapeutics. Cell & Gene Therapy Insights – ISSN: 2059-7800. DOI: 10.18609/cgti.2017.038
Biopreservation Best Practices for Regenerative Medicine GMP Manufacturing & Focus on Optimized Biopreservation Media
Hawkins B, Abazari A, Mathew A. Biopreservation Best Practices for Regenerative Medicine GMP Manufacturing & Focus on Optimized Biopreservation Media. Cell & Gene Therapy Insights – ISSN: 2059-7800. DOI: 10.18609/cgti.2017.035
Biopreservation Best Practices for Regenerative Medicine GMP Manufacturing & Focus on Optimized Biopreservation Media
Hawkins B, Abazari A, Mathew A. Biopreservation Best Practices for Regenerative Medicine GMP Manufacturing & Focus on Optimized Biopreservation Media. Cell & Gene Therapy Insights – ISSN: 2059-7800. DOI: 10.18609/cgti.2017.035
Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine Conjugated Antibody–Drug Conjugate Targeting 5T4
Harper, Lloyd, Dimasi, Toader, Marwood, Lewis, Bannister, Jovanovic, Fleming, d’Hooge, Mao, Marrero, Korade, Strout, Xu, Chen, Wetzel, Breen, van Vlerken-Ysla, Jalla, Rebelatto, Zhong, Hurt, Hinrichs, Huang, Howard, Tice, Hollingsworth, Herbst, Kamal. Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine Conjugated Antibody–Drug Conjugate Targeting 5T4. Mol Cancer Ther; 16(8) August 2017. DOI: 10.1158/1535-7163.MCT-16-0825
Best Practices vs. Traditional Practices of Procedures and Technology for Preserving Viability and Functionality of T-Cells at Both -80 C and -190 C
Fink J, Abazari A, Hawkins B, Albert M, O’Donnell K, Mathew A. Best Practices vs. Traditional Practices of Procedures and Technology for Preserving Viability and Functionality of T-Cells at Both -80 C and -190 C. Biopreservation and Biobanking Volume 15, Number 3, 2017. DOI:10.1089=bio.2017.29021.abstracts
Integrated time-lapse and single-cell transcription studies highlight the variable and dynamic nature of human hematopoietic cell fate commitment
Moussy A, Cosette J, Parmentier R, da Silva C, et al. Integrated time-lapse and single-cell transcription studies highlight the variable and dynamic nature of human hematopoietic cell fate commitment. PLoS Biol 15 (7): e2001867 dos: https://doi.org/10.1101/101428
Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility
Kunkele A, Taraseviciute A, Finn L, Johnson A, et al. Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility Clin Cancer Res; 23(2) January 15, 2017 DOI: 10.1158/1078-0432.CCR-16-0354
In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts
Kadota S, Pabon L, Reinecke H, Murry C. In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts. Stem Cell Reports (2016) DOI: http://dx.doi.org/10.1016/j.stemcr.2016.10.009